Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CD97 encodes a member of the EGF-TM7 subfamily of adhesion G protein-coupled receptors, which mediate cell-cell interactions. Additionally we are shipping CD97 Kits (27) and CD97 Proteins (18) and many more products for this protein.
Showing 10 out of 247 products:
Mouse (Murine) Polyclonal CD97 Primary Antibody for EIA, IF - ABIN401030
Gray, Haino, Roth, Maguire, Jensen, Yarme, Stetler-Stevenson, Siebenlist, Kelly: CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation. in Journal of immunology (Baltimore, Md. : 1950) 1997
Show all 4 references for ABIN401030
Mouse (Murine) Polyclonal CD97 Primary Antibody for FACS, WB - ABIN4900567
Veninga, Becker, Hoek, Wobus, Wandel, van der Kaa, van der Valk, de Vos, Haase, Owens, van der Poll, van Lier, Verbeek, Aust, Hamann: Analysis of CD97 expression and manipulation: antibody treatment but not gene targeting curtails granulocyte migration. in Journal of immunology (Baltimore, Md. : 1950) 2008
Human Monoclonal CD97 Primary Antibody for FACS - ABIN319946
Steinert, Wobus, Boltze, Schütz, Wahlbuhl, Hamann, Aust: Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissues. in The American journal of pathology 2002
These findings demonstrate that CD97 is a positive regulator of osteoclast-like cell differentiation, a mechanism that influences bone homeostasis. However, the presence of CD97 may be essential to suppress the initial osteoclastogenesis that occurs in response to acute and local inflammatory stimuli.
We conclude that CD97 is located in the SR and at the peripheral sarcolemma of human and murine skeletal muscle, where its absence affects the structure of the SR without impairing skeletal muscle function
Intestinal enlargement by CD97 requires its seven-span transmembrane/cytoplasmic C-terminal fragment.
CD55 (show CD55 Antibodies) downregulates CD97 surface expression on circulating leukocytes by a process that requires physical forces.
Insight into a role for CD55 (show CD55 Antibodies) interaction with CD97 in the pathogenesis of rheumatoid arthritis suggest that therapeutic strategies that disrupt CD55 (show CD55 Antibodies)/CD97 may be clinically beneficial.
In vivo findings in experimental colitis and pneumococcal pneumonia indicate an essential role for CD97 in the migration of neutrophils.
CD97 plays a role in peripheral granulocyte homeostasis by functioning in an adhesive capacity.
Mobilization was absent and neutrophils were reduced in mice receiving CD97 mAb plus interleukin-8 (show IL8 Antibodies), while granulocyte-colony stimulating factor (show CSF3 Antibodies)-induced mobilization remained unaltered by anti-CD97. CD97 has a role in IL-8 (show IL8 Antibodies) induced HSC (show FUT1 Antibodies)/HPC mobilization.
In BALB/c mice, CD97 expression can be applied to almost completely separate colony-forming cells and cells exhibiting radioprotective capacity.
Despite the broad expression pattern of wild-type murine CD97, the successfully deleted gene Cd97-deficient mouse that is created has no overt phenotype, except for a mild granulocytosis that is normal in the absence of CD97.
High CD97 expression Correlates with Breast, Colorectal and Pancreatic Cancer.
High expression of CD97 is associated with lymphatic metastasis in gastric cancer.
This study indicated that the CD97 and CD55 (show CD55 Antibodies) proteins might be reliable biomarkers to predict the metastasis status and prognosis of intrahepatic cholangiocarcinoma patients.
Knock down of CD97 led to an altered mechanical phenotype, reduced adhesion to a stromal layer and lower wildtype FLT3 (show FLT3 Antibodies) expression.
present study suggested that the expressions of CD97 antigen and decay accelerating factor(DAF (show CD55 Antibodies)) were both upregulated in human cervical squamous cell carcinoma
CD97 promotes gastric cancer cell proliferation and invasion in vitro through exosome-mediated MAPK (show MAPK1 Antibodies) signaling pathway, and exosomal miRNAs are probably involved in activation of the CD97-associated pathway.
we identify the specific isoforms of CD97, a novel pro-invasive glioma antigen, across histologic grades of glioma and within BTICs. We also demonstrate a trend towards increased CD97 expression among the classical and mesenchymal GBM subtypes.
CD97 enhanced TIMP-2 (show TIMP2 Antibodies) secretion, leading to reduced MT-MMP-1 (show MMP14 Antibodies) and -2 activities, impairing cell migration/invasion in vitro and lung macrometastasis in vivo and upregulating integrins. Both the NTF (show RHBDL2 Antibodies) and the CTF (show NFIA Antibodies) of CD97 were required.
These results provide the first experimental evidence that cd97 is a direct target of miR (show MLXIP Antibodies)-126.
This gene encodes a member of the EGF-TM7 subfamily of adhesion G protein-coupled receptors, which mediate cell-cell interactions. These proteins are cleaved by self-catalytic proteolysis into a large extracellular subunit and seven-span transmembrane subunit, which associate at the cell surface as a receptor complex. The encoded protein may play a role in cell adhesion as well as leukocyte recruitment, activation and migration, and contains multiple extracellular EGF-like repeats which mediate binding to chondroitin sulfate and the cell surface complement regulatory protein CD55. Expression of this gene may play a role in the progression of several types of cancer. Alternatively spliced transcript variants encoding multiple isoforms with 3 to 5 EGF-like repeats have been observed for this gene. This gene is found in a cluster with other EGF-TM7 genes on the short arm of chromosome 19.
, CD97 antigen
, leukocyte antigen CD97
, seven transmembrane helix receptor
, seven-span transmembrane protein
, seven-transmembrane, heterodimeric receptor associated with inflammation
, CD97 large isoform